202 related articles for article (PubMed ID: 26620464)
1. Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.
Mes SW; Leemans CR; Brakenhoff RH
Expert Rev Mol Diagn; 2016; 16(2):205-21. PubMed ID: 26620464
[TBL] [Abstract][Full Text] [Related]
2. Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
Economopoulou P; Bourhis J; Psyrri A
Am Soc Clin Oncol Educ Book; 2015; ():e323-8. PubMed ID: 25993192
[TBL] [Abstract][Full Text] [Related]
3. The emerging era of personalized therapy in squamous cell carcinoma of the head and neck.
Pryor DI; Solomon B; Porceddu SV
Asia Pac J Clin Oncol; 2011 Sep; 7(3):236-51. PubMed ID: 21884435
[TBL] [Abstract][Full Text] [Related]
4. [Metastatic oropharyngeal squamous cell carcinoma in cervical lymph nodes associated to HPV infection type 16 and 45; clinical, morphological and molecular study of two cases].
Soria-Céspedes D; Canchola Aguilar G; Lara-Torres CO; Sánchez-Marle JF; Hernández-Peña RE; Ortiz-Hidalgo C
Gac Med Mex; 2013; 149(6):673-9. PubMed ID: 24276191
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
6. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas.
Roepman P; Wessels LF; Kettelarij N; Kemmeren P; Miles AJ; Lijnzaad P; Tilanus MG; Koole R; Hordijk GJ; van der Vliet PC; Reinders MJ; Slootweg PJ; Holstege FC
Nat Genet; 2005 Feb; 37(2):182-6. PubMed ID: 15640797
[TBL] [Abstract][Full Text] [Related]
7. Rationale for sentinel node biopsy to stage N0 head and neck squamous-cell carcinoma.
Ross G
Cancer Biother Radiopharm; 2004 Jun; 19(3):273-84. PubMed ID: 15285874
[TBL] [Abstract][Full Text] [Related]
8. Head and neck oncology--2010, part II.
Myers EN
Otolaryngol Pol; 2010; 64(4):204-14. PubMed ID: 20873095
[TBL] [Abstract][Full Text] [Related]
9. [Current trends in diagnosis and treatment head and neck cancer].
Lacau St Guily JL
Rev Prat; 2006 Oct; 56(15):1652-7. PubMed ID: 17137249
[TBL] [Abstract][Full Text] [Related]
10. Head and neck oncology--2010, Part I.
Myers EN
Otolaryngol Pol; 2010; 64(3):136-46. PubMed ID: 20731202
[TBL] [Abstract][Full Text] [Related]
11. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma.
Shores CG; Yin X; Funkhouser W; Yarbrough W
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):937-42. PubMed ID: 15313863
[TBL] [Abstract][Full Text] [Related]
13. Leveraging Genomics for Head and Neck Cancer Treatment.
Kemmer JD; Johnson DE; Grandis JR
J Dent Res; 2018 Jun; 97(6):603-613. PubMed ID: 29420101
[TBL] [Abstract][Full Text] [Related]
14. A liquid biopsy for head and neck cancers.
Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C
Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411
[TBL] [Abstract][Full Text] [Related]
15. Cancer of unknown primary in the head and neck: Diagnosis and treatment.
Ota I; Kitahara T
Auris Nasus Larynx; 2021 Feb; 48(1):23-31. PubMed ID: 32888761
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.
van Dongen GA; Brakenhoff RM; ten Brink CT; van Gog FB; de Bree R; Quak JJ; Snow GB
Anticancer Res; 1996; 16(4C):2409-13. PubMed ID: 8816843
[TBL] [Abstract][Full Text] [Related]
17. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
18. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung.
Weichert W; Schewe C; Denkert C; Morawietz L; Dietel M; Petersen I
Am J Surg Pathol; 2009 Apr; 33(4):513-20. PubMed ID: 19145203
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of microvessel density and p53 expression on the locoregional metastasis and survival of the patients with head and neck squamous cell carcinoma.
de Oliveira MV; Pereira Gomes EP; Pereira CS; de Souza LR; Barros LO; Mendes DC; Guimarães AL; De Paula AM
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):444-51. PubMed ID: 23343952
[TBL] [Abstract][Full Text] [Related]
20. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
